News Shortcuts from other journals

Cituximab buys more time for some people with advanced colorectal cancer

BMJ 2007; 335 doi: (Published 22 November 2007) Cite this as: BMJ 2007;335:1071

Traditional cytotoxic treatments for cancer preferentially kill rapidly dividing cells. More recently, researchers have turned their attention to the growth factors expressed by some cancers, targeting them with specifically designed monoclonal antibodies. Cituximab is one such antibody, directed against the epidermal growth …

View Full Text

Log in

Log in through your institution


* For online subscription